Acidic FGF induces NGF and its mRNA in the injured neocortex of adult animals.
Recently we reported that human recombinant acidic fibroblast growth factor (aFGF) is capable of preventing degeneration of nucleus basalis magnocellularis neurons in vivo and inducing growth of astrocytes in vitro. In the present study, the effects of aFGF on the concentration of nerve growth factor (NGF) and its messenger RNA were investigated in the rat cerebral cortex following unilateral cortical infarction. Lesioned animals exhibited a significant increase of NGF in the remaining cortex ipsilateral to the lesion. After combining cortical lesion with intracerebroventricular application of aFGF (12 micrograms/day for 7 days), we observed an 8-fold increase in the NGF concentration and a marked increase in the level of steady state NGF mRNA relative to controls ipsilaterally, and a less pronounced aFGF effect in the contralateral cerebral cortex. These results support the hypothesis that the neurotrophic effects previously shown for aFGF and basic FGF (bFGF) in neurotrophin-sensitive neurons is mediated by inducing increased production of NGF within the injured central nervous system (CNS) of adult animals.
Figueiredo
B C
BC
Department of Pharmacology and Therapeutics, McGill University, Montreal, Que., Canada.
Plüss
K
K
Skup
M
M
Otten
U
U
Cuello
A C
AC
D000818:Animals; D001483:Base Sequence; D002540:Cerebral Cortex / Q000187:drug effects* / Q000378:metabolism; D002544:Cerebral Infarction / Q000188:drug therapy* / Q000378:metabolism; D016220:Fibroblast Growth Factor 1 / Q000627:therapeutic use*; D007276:Injections, Intraventricular; D008297:Male; D008969:Molecular Sequence Data; D009414:Nerve Growth Factors / Q000096:biosynthesis / Q000235:genetics*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar
D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D016220:Fibroblast Growth Factor 1